Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2026-01-05 @ 6:01 PM
Study NCT ID:
NCT02377466
Status:
TERMINATED
Last Update Posted:
2020-07-28
First Post:
2015-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-29
Start Date Type:
ACTUAL
Primary Completion Date:
2017-07-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-24
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-26
First Submit QC Date:
None
Study First Post Date:
2015-03-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-01-22
Results First Submit QC Date:
None
Results First Post Date:
2018-07-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-14
Last Update Post Date:
2020-07-28
Last Update Post Date Type:
ACTUAL